Search

everythinglearnresearchcommunity

for

Search:↓

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

A new treatment for hair loss shows promise with fewer side effects.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

A new treatment plan for hair loss combines targeted therapies and regenerative strategies to stabilize, reverse, and maintain hair growth.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Analog 23 is a promising compound for prostate cancer treatment.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

AH-001 could be a safer and more effective treatment for hair loss.

GPR40 agonists help hair growth through the protein ANGPTL4.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

New steroids were effective in blocking male hormone receptors in hamster prostates.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Blocking certain brain processes reduces mating behavior in female rats.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

The document concludes that the androgen receptor's structure and function are complex, affecting how it regulates genes and is involved in diseases like prostate cancer.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.